Demographic characteristics and comorbid disorder comparisons between the ESRD and control groups
| ESRD (n=92 967) | Controls (n=92 967) | p Value | |
| n (%) | n (%) | ||
| Age on the index date (years; mean±SD) | 62.23±14.64 | 62.23±16.64 | 1.0000 |
| Age on the index date | |||
| <50 years | 18 015 (19.38) | 18 015 (19.38) | 1.0000 |
| 50–64 years | 29 723 (31.97) | 29 723 (31.97) | |
| ≥65 years | 45 229 (48.65) | 45 229 (48.65) | |
| Sex | |||
| Male | 46 039 (49.52) | 46 039 (49.52) | 1.0000 |
| Female | 46 928 (50.48) | 46 928 (50.48) | |
| Baseline comorbidity | |||
| DM | 48 928 (52.63) | 10 177 (11.03) | <0.001 |
| HIV disease | 19 (0.02) | 12 (0.01) | 0.2086 |
| Follow-up (years) (mean±SD) | 4.70±3.26 | 6.49±2.96 | <0.001 |
Demographic characteristics and comorbid disorders were compared between the ESRD and control groups using Pearson’s Χ2 tests.
DM, diabetes mellitus; ESRD, end-stage renal disease.